Join The Community

Summary

The product VAR 25mg (Oxandrolone) underwent independent testing to verify its authenticity and potency. The sample, submitted by asteroidbiotech@proton.me, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxandrolone, with a recorded concentration of 28.57 mg, exceeding the labeled claim of 25 mg by 14.28%.

The testing process began on 21 October 2024, with the sample received on 7 November 2024, and analysis completed on 15 November 2024. While the results confirm accurate dosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.

Detailed Report

Product Overview

Testing Details

Testing Results

Verification Details

Evaluation of Manufacturer-Submitted Testing

This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by asteroidbiotech@proton.me. Manufacturer may select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.

Conclusion

The analysis confirms that VAR 25mg (Oxandrolone) is slightly overdosed, with a measured concentration of 28.57 mg. This result reflects acceptable quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.

Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.